Eduard Gasal
- Oncology top 2%
- CAR-T cell therapy research 11
- Cancer Immunotherapy and Biomarkers 10
- Colorectal Cancer Treatments and Studies 7
- HER2/EGFR in Cancer Research 4
- Genetics top 5%
- Cancer Research top 10%
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 28
- Protein Degradation and Inhibitors 6
- Pathology and Forensic Medicine top 10%
-
- Click Chemistry and Applications 7
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Georgina V. LongKeith T. FlahertyPalanichamy IlankumaranPaul BurgessAlexander SteinOmid HamidVivek SubbiahZev A. Wainberg
- Cited by
- OncologyGeneticsCancer Research
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Eduard Gasal
44 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 1.0k
- Genetics 208
- Cancer Research 233
- Molecular Biology 720
- Pathology and Forensic Medicine 186
Countries citing papers authored by Eduard Gasal
This map shows the geographic impact of Eduard Gasal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Gasal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Gasal more than expected).
Fields of papers citing papers by Eduard Gasal
This network shows the impact of papers produced by Eduard Gasal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Gasal. The network helps show where Eduard Gasal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eduard Gasal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 19 | |
| 3 | 2021 | 141 | |
| 4 | 2021 | 70 | |
| 5 | 2020 | 111 | |
| 6 | 2020 | 50 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 48 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 85 | |
| 11 | Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trialbreakdown → | 2020 | 314 |
| 12 | 2019 | 125 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 1 | |
| 15 | 2017 | 60 | |
| 16 | 2017 | 84 | |
| 17 | 2017 | 167 | |
| 18 | 2016 | 15 | |
| 19 | 2014 | 4 | |
| 20 | 2003 | 6 |
About Eduard Gasal
Eduard Gasal is a scholar working on Oncology, Genetics and Molecular Biology, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (28 papers), CAR-T cell therapy research (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Click Chemistry and Applications (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Protein Degradation and Inhibitors (6 papers), Lung Cancer Treatments and Mutations (6 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (1.0k citations), Genetics (208 citations) and Cancer Research (233 citations). Eduard Gasal has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Georgina V. Long, Keith T. Flaherty, Palanichamy Ilankumaran, Paul Burgess, Alexander Stein, Omid Hamid, Vivek Subbiah, Zev A. Wainberg, Aislyn Boran and Giuseppe Curigliano. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.